ACS C&EN | Webinar

Eliminate Barriers of Conventional Immunoassays with a Customizable qPCR-based High-Performance Assay Platform

Date
November 13, 2018

Time
8:00 a.m. PST / 11:00 a.m. EST / 16:00 GMT / 17:00 CET - Duration: 60 Minutes

Date : November 13, 2018

Time : 8:00 a.m. PST / 11:00 a.m. EST / 16:00 GMT / 17:00 CET - Duration: 60 Minutes

Registration

First Name *

Last Name *

Email *

Confirm Email *

Company *

Address 1

Address 2

City *

State or Province *

Zip or Postal Code *

Country *

Phone

Yes, I would like a demo from Thermo Fisher Scientific

Yes, I would like a quote from Thermo Fisher Scientific

Yes, I would like to be contacted by a Thermo Fisher Scientific sales representative

Yes, I would like to receive email communications about Thermo Scientific products, events and special offers pertaining to my interests.
By completing and submitting this form, you understand and agree that use of American Chemical Society (ACS) websites are subject to the ACS Terms of Use and ACS Privacy Policy, including the fact that ACS and its third party sponsors can contact you based on the information provided. In order to process your registration completely, you understand that your information will be transferred to ACS’ affiliates globally.

* Required

Overview ▼
ProteinSEQ^TM, a qPCR-based ultra-high performance assay platform, enables easily customizable quantitative assays with high sensitivity, dynamic range, linearity, recovery, precision, and assay robustness. The system combines semi-automated magnetic bead-based protein antigen extraction with quantitative real-time PCR as readout. Its many advantages in assay workflow, robustness, and technical superiority make it an ideal assay platform system for ELISA replacement and streamlined bioprocessing. This study describes the use of customized ProteinSEQ assays in several quantitative applications in which the same ELISA capture/detection antibodies used on the ProteinSEQ platform resulted in orders of magnitude improvements in assay performance.
Read more ▼
Key Learning Objectives
- A rapid alternative for ELISA
- A custom process-specific HCP and leached protein assay
- A customized assay that provides order of magnitude improvement over ELISA
Who Should Attend
- Lab Managers
- Research Scientists
- Core Facility Managers
- Production/Process Engineers
- Principal Investigators
- Staff Scientists
- Regulatory QA/QC
Brought to you by:

Speakers ▼

Bharti Solanki is a Scientist at Thermo Fisher Scientific and has worked in biotechnology companies for over 8 years. Bharti received her B.S. in Genetics from the University of California, Davis and her Ph.D. from the University of Wisconsin, Madison. She was an NIH minority fellowship recipient where she worked on the maternal effect mutations in zebrafish, Danio rerio. Bharti completed her industrial post-doctoral work at a startup and later joined Thermo Fisher Scientific. Her tenure at Thermo includes qPCR assays, Glycan technologies, software development and testing and PLA technologies.

Alexandra Taylor,
Moderator, Assistant Editor,
C&EN